Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Kaiseron Sep 20, 2021 5:33pm
168 Views
Post# 33890316

RE:Any thoughts on what

RE:Any thoughts on what

Very unlikely.  HC hasn't even began the recruiting stage of this study and I don't see fda communicating with hc.

HC would be nice but it is a peanut compared to the fda and the potential for earnings.  Don't take this as a bashing post so I can get "cheap shares" like you think it's just critical thinking. 

Why has HC waited this long to even consider a Thermas test?  It's who you know and not what you know.  If the pockets are not being lined it's a slow process.  

 


Boudi1959 wrote: Mariner on yahoo board posted below? Could be it, who knows? But it makes sense to me that what the FDA asked Therma for more things?

The clinical trial listed on HC site, approved Sept. 16 2021, might be part of the ongoing FDA review?
I imagine that, if the rapid saliva test is going to be used in schools, then part of the tested subjects should be children?  
Or FDA is trying to stall
This clinical trial (May 2021) was never started, so now is a good time. They know exactly what FDA is looking for and what/who they need to test for additional approvals.
McMasters, hurry up. 
Your thoughts?

 

<< Previous
Bullboard Posts
Next >>